ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SGMO Sangamo Therapeutics Inc

0.6247
0.00 (0.00%)
Pre Market
Last Updated: 07:00:00
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Sangamo Therapeutics Inc SGMO NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 0.6247 07:00:00
Open Price Low Price High Price Close Price Prev Close
0.6247
more quote information »

Recent News

Date Time Source Heading
3/27/202410:52IHNWFeaturedPOET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks
3/22/202408:05BWSangamo Therapeutics Announces Pricing of $24.0 Million..
3/13/202408:05BWSangamo Therapeutics Reports Recent Business Highlights and..
3/13/202408:01BWSangamo Therapeutics Announces Data From Novel Proprietary..
3/12/202418:30BWSangamo Therapeutics Announces Fourth Quarter and Full Year..
2/27/202417:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/27/202417:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/27/202417:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/27/202417:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/27/202417:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/12/202408:05BWSangamo Therapeutics Announces U.S. FDA Alignment on..
2/06/202416:35EDGAR2Form 8-K - Current report
2/05/202418:01BWSangamo Therapeutics Announces Updated Phase 1/2 STAAR Study..
1/26/202411:49EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/24/202416:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/24/202416:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/24/202416:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/24/202416:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/24/202416:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/19/202417:09EDGAR2Form 8-K - Current report
12/13/202307:55EDGAR2Form 8-K - Current report
11/28/202316:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/28/202316:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/28/202316:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/28/202316:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/28/202316:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/28/202316:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/28/202316:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/03/202316:02EDGAR2Form 8-K - Current report
11/01/202316:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/01/202316:02EDGAR2Form 8-K - Current report
11/01/202316:01BWSangamo Therapeutics Announces Strategic Update and Reports..
10/25/202316:15BWSangamo Therapeutics Announces Third Quarter 2023 Conference..
10/24/202302:01BWSangamo Therapeutics to Present Pre-Clinical Data Showcasing..
9/20/202316:15BWSangamo Therapeutics to Present at the Jefferies Cell &..
8/29/202316:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/29/202316:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/29/202316:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/29/202316:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/29/202316:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/29/202316:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/15/202316:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/08/202316:47EDGAR2Form S-8 - Securities to be offered to employees in employee..
8/08/202316:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/08/202316:08EDGAR2Form 8-K - Current report
8/08/202316:01BWSangamo Therapeutics Reports Recent Business Highlights and..
8/01/202316:15BWSangamo Therapeutics Announces Second Quarter 2023..
7/20/202308:05BWSangamo Therapeutics and Chroma Medicine Announce Option and..
7/17/202308:05BWSangamo Therapeutics Announces Research Evaluation and..
6/29/202308:05BWSangamo Therapeutics and Voyager Therapeutics Enter License..
5/22/202308:05BWSangamo Therapeutics Receives U.S. FDA Fast Track..

Your Recent History

Delayed Upgrade Clock